UCSF’s innovative, collaborative approach to patient care, research and education spans disciplines across the life sciences, making it a world leader in scientific discovery and its translation to improving health.
Kailey Mateo is the GBHI Monitoring and Evaluation Coordinator based at UCSF. She works with the Monitoring and Evaluation team to provide ongoing support for the monitoring and learning activities of the program and is helping to expand into new arenas, such as evaluating social impact.
Mindy supports the learning environment at the Global Brain Health Institute (GBHI), both online and in the classroom. She is adapting her expertise as a teacher educator from traditional classroom environments for a "flipped" class and remote learning while also supporting faculty to adapt content for this new environment.
Sarah McDonagh supports the Atlantic Fellows for Equity in Brain Health and faculty within the Global Brain Health Institute to implement research projects and new grant applications, with a focus on the ReDLat project.
Diana is a clinical research coordinator for the NIH-designated Alzheimer’s Disease Research Center at the Memory and Aging Center, where she coordinates visits for Mandarin-speaking participants. She graduated from UC Davis with a Bachelor of Science degree in Neurobiology, Physiology and Behavior.
Dr. Zachary Miller grew up in the Washington DC metro area. He obtained an undergraduate degree double majoring in Molecular Biology and Fine Arts from Haverford College. Following this he spent two years as a research assistant at MIT’s Whitehead Institutes for Biomedical Research in Dr. Harvey Lodish’s lab. He received his medical degree from the University of Pittsburgh and pursued medical internship as well as neurology residency training at the University of Washington.
Bruce L. Miller, MD, holds the A.W. and Mary Margaret Clausen Distinguished Professorship in Neurology at the University of California, San Francisco, directs the UCSF Memory and Aging Center and is the founding director of the Global Brain Health Institute at UCSF. In addition, he helps lead the Tau Consortium and The Bluefield Foundation, precision medicine collaborations focused on developing treatments for tauopathies and progranulin-mediated forms of frontotemporal dementia.
Laura Mitic, PhD, is the Chief Scientific Officer at the Bluefield Project to Cure Frontotemporal Dementia. Dr. Mitic holds a BA degree from Northwestern University and a doctorate degree in cell biology from Yale University. She completed postdoctoral studies at the University of California, San Francisco. She and her husband live in San Francisco with their two children.
Greg received his bachelor's degree in Microbiology from Brigham Young University where he developed a new class of influenza inhibitors. He completed his PhD degree at UCSF in Martin Kampmann's Lab. In the Kampmann lab, he studied how the V337M tau mutation perturbs differentiating iPSC-derived neurons. Greg works with the Clelland Lab at the Memory and Aging Center to develop new methods for screening nanoparticle delivery of gene editing therapies.
